COMMUNIQUÉS West-GlobeNewswire

KemPharm Reports First Quarter 2019 Results
14/05/2019
Development & Regulatory Highlights: Completed KP415 Pre-NDA Meeting with FDA Provided Update on APADAZ ® Formulary Adoption Announced FDA Approval of sNDA for Two Additional Strengths of APADAZ Corporate & [...]
TRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
14/05/2019
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Genesis HealthCare to Present at 2019 RBC Capital Markets Global Healthcare Conference
14/05/2019
KENNETT SQUARE, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced that George V. Hager, Jr., Chief [...]
OpGen Reports First Quarter 2019 Financial Results and Provides Business Update
14/05/2019
Submission of 510(k) application to the FDA for clearance of the Acuitas ® AMR Gene Panel test for bacterial isolates Revenue up 21% Quarter-over-Quarter Conference call to be held at 4:30 p.m. Eastern time today [...]
Acer Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
14/05/2019
Acer executing on pre-commercial launch plan for EDSIVO™ while growing and advancing its pipeline NEWTON, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused [...]
Daré Bioscience Reports First Quarter 2019 Financial Results and Company Update
14/05/2019
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the first quarter ended March 31, 2019 and provided a Company [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
14/05/2019
Company Announcement Copenhagen, Denmark; May 14, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 9,737 shares as a consequence of the exercise of employee warrants. The increase is [...]
Chapin Aesthetics Begins Offering Microneedling and PRP for the Philadelphia Area
14/05/2019
2019 marks the debut of a skin-revitalizing treatment offered by Dr. Scott D. Chapin and his team DOYELSTOWN, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- As a plastic surgeon in the Philadelphia area , Dr. Scott D. Chapin has [...]
During Skin Cancer Awareness Month, Dermatologists Share 5 Common Sunscreen Mistakes — and How to Avoid Them; American Academy of Dermatology
14/05/2019
ROSEMONT, Ill., May 14, 2019 (GLOBE NEWSWIRE) -- Skin cancer is the most common cancer in the United States, affecting one in five Americans in their lifetime. Yet according to dermatologists from the American Academy [...]
Tauriga Sciences Inc. to Commence Initial Production Run of Blood Orange Flavored Version of Tauri-Gum
14/05/2019
New York, NY, May 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and [...]
UK Annual Report and Notice of AGM
14/05/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Publication of UK Annual Report and Notice of Annual General Meeting Oxford, UK, and Cambridge, MA, US, 14 May 2019 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT [...]
Amedisys to Present at the 2019 RBC Capital Markets Healthcare Conference
14/05/2019
BATON ROUGE, La., May 14, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief [...]
Bavarian Nordic to Host First Quarter 2019 Results Conference Call
14/05/2019
COPENHAGEN, Denmark – May 14, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2019 first quarter results on Wednesday, May 22, 2019. The management of Bavarian Nordic will host a conference call at [...]
Kalytera Therapeutics, Inc. Announces Second Closing of Public Offering
14/05/2019
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANCISCO and TEL AVIV, [...]
Respected Neurosurgeon Brings Distinguished Career and Medical Expertise to Geocann’s Executive Management Team
14/05/2019
Anthony Petraglia, M.D., joins Geocann as Chief Medical Officer to focus on the advancement of new product innovations that target the most pressing consumer health concerns as well as the research and publication of [...]
Colibri Heart Valve to Present One-Year Patient Follow-Up Results from Clinical Feasibility Study of Second-Generation TAVI System at EuroPCR
14/05/2019
BROOMFIELD, CO , May 14, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC , a privately held emerging medical device company, today announced that results from the company’s international, single-arm, open-label early [...]
Y-mAbs Announces Development Update on Cancer Vaccine Program
14/05/2019
NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, [...]
CURE Pharmaceutical (OTCQB:CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
14/05/2019
Acquired Technology Expands Core CUREfilmTM Platform and Strengthens Balance Sheet OXNARD, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development [...]
Oxford Immunotec to Present at the UBS Global Healthcare Conference
14/05/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that Dr. Peter [...]

Pages